Matthes H, Seward E P, Kieffer B, North R A
Glaxo Institute for Molecular Biology, Geneva, Switzerland.
Mol Pharmacol. 1996 Sep;50(3):447-50.
An opioid-like receptor has been cloned by several groups of researchers and recently shown to be activated by an endogenous heptadecapeptide termed orphanin FQ (or nociceptin). We isolated the corresponding mouse cDNA and coexpressed it in Xenopus laevis oocytes with the potassium channel subunits Kir3.1 (GIRK1) and Kir3.4 (CIR, rcKATP). Orphanin FQ evoked potassium currents, with 50% of the maximal effect at approximately 1 nM; [Tyr1]orphanin FQ was equally effective, and des-pheorphanin FQ was without activity. Dynorphin A, dynorphin(1-9), dynorphin(1-13), and alpha-neoendorphin were > 100 times less potent, and other agonists active at mu-, delta-, and kappa-opioid receptors had no effect. Naloxone (1 microM) and norbinaltorphimine (1 microM) had no antagonist action. Conversely, oocytes expressing kappa receptors responded to dynorphin (half-maximal concentration, 0.3 nM) but not to orphanin FQ. Thus, both kappa and orphanin FQ receptors readily couple to potassium channels, but the highly selective activation by dynorphin and orphanin FQ is consistent with distinct functional pathways in vivo.
几组研究人员已克隆出一种阿片样受体,最近发现它可被一种名为孤啡肽FQ(或痛敏肽)的内源性十七肽激活。我们分离出了相应的小鼠cDNA,并将其与钾通道亚基Kir3.1(GIRK1)和Kir3.4(CIR,rcKATP)在非洲爪蟾卵母细胞中共表达。孤啡肽FQ可诱发钾电流,在约1 nM时达到最大效应的50%;[酪氨酸1]孤啡肽FQ同样有效,而脱苯丙氨酸孤啡肽FQ则无活性。强啡肽A、强啡肽(1-9)、强啡肽(1-13)和α-新内啡肽的效力低100倍以上,其他对μ-、δ-和κ-阿片受体有活性的激动剂则无作用。纳洛酮(1 μM)和去甲左啡诺(1 μM)无拮抗作用。相反,表达κ受体的卵母细胞对强啡肽有反应(半数最大浓度,0.3 nM),但对孤啡肽FQ无反应。因此,κ受体和孤啡肽FQ受体都能轻易地与钾通道偶联,但强啡肽和孤啡肽FQ的高度选择性激活与体内不同的功能途径一致。